Cardiff Oncology (CRDF) Current Leases (2019 - 2026)
Cardiff Oncology (CRDF) posted Current Leases of $730000.0 for Q4 2025, up 0.55% sequentially from $726000.0 in Q3 2025, and up 2.82% YoY from $710000.0 in Q4 2024.
Cardiff Oncology (CRDF) Current Leases (2019 - 2026) Analysis & Trends
Cardiff Oncology has reported Current Leases for 7 years, with the latest figure at $730000.0 in Q4 2025.
- Quarterly Current Leases rose 2.82% year-over-year to $730000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $730000.0 (up 2.82% YoY) and the FY2025 annual result came in at $730000.0, up 2.82% from the prior year.
- Current Leases grew to $730000.0 in Q4 2025 per CRDF's latest filing, from $726000.0 in the prior quarter.
- Over five years, Current Leases peaked at $730000.0 in Q4 2025 and troughed at $402000.0 in Q2 2021.
- A 5-year average of $665750.0 and a median of $685500.0 in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2021 and 2022: Current Leases tumbled 54.19% in 2021, then jumped 66.67% in 2022.
- Over 5 years, Current Leases stood at $551000.0 in 2021, then grew by 22.5% to $675000.0 in 2022, then increased by 2.37% to $691000.0 in 2023, then grew by 2.75% to $710000.0 in 2024, then gained by 2.82% to $730000.0 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $730000.0, $726000.0, and $721000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cardiff Oncology | 60.21 Mn | 60.21 Mn | - | 457,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 457,000.00 |
| Dec 31, 2025 | 730,000.00 |
| Sep 30, 2025 | 726,000.00 |
| Jun 30, 2025 | 721,000.00 |
| Mar 31, 2025 | 716,000.00 |
| Dec 31, 2024 | 710,000.00 |
| Sep 30, 2024 | 707,000.00 |
| Jun 30, 2024 | 702,000.00 |
| Mar 31, 2024 | 696,000.00 |
| Dec 31, 2023 | 691,000.00 |
| Sep 30, 2023 | 688,000.00 |
| Jun 30, 2023 | 683,000.00 |
| Mar 31, 2023 | 679,000.00 |
| Dec 31, 2022 | 675,000.00 |
| Sep 30, 2022 | 674,000.00 |
| Jun 30, 2022 | 670,000.00 |
| Mar 31, 2022 | 665,000.00 |
| Dec 31, 2021 | 551,000.00 |
| Sep 30, 2021 | 594,000.00 |
| Jun 30, 2021 | 402,000.00 |